Nasopharyngeal Polyp

A nasopharyngeal polyp is a benign, pedunculated, inflammatory fibrovascular growth that arises from the mucosal lining of the nasopharynx, middle ear, or eustachian tube. It is most commonly diagnosed in young cats, although it can occur in dogs and occasionally in other species. The polyp typically extends into the nasopharynx, causing partial or complete obstruction of the airway, and may also involve the external ear canal via extension through the tympanic membrane. Surgical excision is the treatment of choice, with traction-avulsion and ventral bulla osteotomy being the primary techniques. The condition is classified based on location (nasopharyngeal, aural, or both) and extent of middle ear involvement. Complete surgical removal is essential to prevent recurrence, which is more common when the polyp originates from the middle ear and is not fully excised.

The exact etiology of nasopharyngeal polyps remains unclear, but several theories have been proposed. Chronic inflammation of the upper respiratory tract or middle ear, possibly due to viral (e.g., feline herpesvirus, calicivirus) or bacterial infections, is considered a primary trigger. The inflammatory process leads to hyperplasia of the mucosal epithelium and underlying connective tissue, forming a polypoid mass. Congenital or developmental anomalies of the branchial arches have also been suggested, as polyps are often diagnosed in young cats. Additionally, chronic irritation from foreign bodies or parasites may contribute. The polyp typically originates from the mucosa of the tympanic cavity or eustachian tube, and its growth is driven by ongoing inflammation and fibrosis. The exact cellular mechanisms involve proliferation of fibroblasts and inflammatory cells, with angiogenesis supporting the growth of the fibrovascular core.

Nasopharyngeal polyps are most commonly diagnosed in cats, with a median age of onset between 1 and 5 years, although they can occur in kittens as young as 3 months and in older cats. There is no strong breed predisposition, but domestic shorthair and longhair cats are frequently represented. Some studies suggest a slight male predominance, but this is not consistent. In dogs, the condition is rare but has been reported in young adults, particularly in breeds such as the Labrador Retriever and Cocker Spaniel. The incidence in cats is estimated to be around 0.5-1% of all feline upper respiratory cases. No specific genetic or sex-linked risk factors have been identified, but young age and a history of upper respiratory infections are considered risk factors.

The pathophysiology of nasopharyngeal polyps involves a chronic inflammatory response that leads to mucosal hyperplasia and polyp formation. The polyp typically arises from the mucosa of the tympanic cavity, eustachian tube, or nasopharynx. The inflammatory stimulus, possibly infectious or irritative, triggers an influx of inflammatory cells (lymphocytes, plasma cells, neutrophils) and the release of cytokines and growth factors, such as transforming growth factor-beta (TGF-β) and vascular endothelial growth factor (VEGF). These mediators promote fibroblast proliferation, collagen deposition, and angiogenesis, resulting in a fibrovascular core covered by respiratory epithelium. As the polyp grows, it may extend through the eustachian tube into the nasopharynx, causing partial or complete airway obstruction. If the polyp originates in the middle ear, it can cause otitis media, leading to hearing loss, vestibular signs, and potential extension into the external ear canal through a ruptured tympanic membrane. The mass effect of the polyp can also cause secondary bacterial infections, mucoid discharge, and chronic inflammation of adjacent tissues.

Intrinsic risk factors include young age (typically <5 years), which may reflect a developmental susceptibility or increased exposure to infectious agents. Anatomical factors, such as a short, straight eustachian tube in cats, may facilitate the extension of inflammation from the nasopharynx to the middle ear. Genetic factors are not well-defined, but certain breeds may have a higher incidence. Extrinsic factors include a history of upper respiratory infections (viral or bacterial), which can trigger chronic inflammation. Environmental factors such as poor ventilation, overcrowding, and stress may increase the risk of infectious respiratory disease. Prior episodes of otitis media or externa may also predispose to polyp formation. Additionally, iatrogenic factors, such as incomplete surgical removal of a previous polyp, can lead to recurrence.

Clinical signs of nasopharyngeal polyps are primarily related to upper respiratory obstruction and middle ear involvement. Common signs include stertor (noisy breathing), nasal discharge (serous, mucoid, or purulent), sneezing, dysphagia, and voice change. Cats may also exhibit open-mouth breathing, exercise intolerance, and cyanosis in severe cases. If the middle ear is affected, signs of otitis media may be present, including head shaking, ear scratching, otorrhea, and vestibular signs such as head tilt, nystagmus, and ataxia. On physical examination, a soft tissue mass may be visible in the nasopharynx on oral examination, often requiring sedation or anesthesia for adequate visualization. The polyp may be seen protruding from the external ear canal if it has extended through the tympanic membrane. Pain on palpation of the ear or throat may be noted. In chronic cases, weight loss and lethargy may occur due to difficulty eating and breathing.

Differential diagnoses for nasopharyngeal polyps include: 1) Neoplasia (e.g., lymphoma, squamous cell carcinoma, adenocarcinoma) – these are more common in older animals and may show aggressive features on imaging; biopsy is needed for definitive diagnosis. 2) Inflammatory polyps of the ear (aural polyps) – these are similar but may be confined to the ear canal; they can be distinguished by imaging and surgical findings. 3) Foreign body (e.g., grass awn) – may cause similar signs but is typically acute in onset and may be visible on imaging or endoscopy. 4) Chronic rhinitis/sinusitis – may cause nasal discharge and stertor, but imaging shows diffuse mucosal thickening rather than a discrete mass. 5) Nasopharyngeal stenosis – a fibrotic band causing obstruction, often secondary to chronic inflammation; imaging and endoscopy can differentiate. 6) Abscess or granuloma – may present as a mass, but imaging and cytology can help. 7) Congenital anomalies (e.g., choanal atresia) – present in young animals with signs from birth. 8) Parasitic infection (e.g., Cuterebra) – may cause a mass-like lesion; history and imaging can help. Definitive diagnosis requires imaging (CT/MRI) and histopathology.

The diagnostic algorithm for nasopharyngeal polyps begins with a thorough history and physical examination, including oral examination and otoscopy. If a polyp is suspected, the next step is diagnostic imaging. Radiography of the skull (lateral and ventrodorsal views) may reveal a soft tissue mass in the nasopharynx or increased opacity in the tympanic bulla, but it is not highly sensitive. Computed tomography (CT) is the imaging modality of choice, as it provides detailed assessment of the nasopharynx, tympanic bullae, and middle ear. CT can identify the presence of a polyp, its origin, and the extent of middle ear involvement (e.g., soft tissue opacification of the bulla). Magnetic resonance imaging (MRI) may be used if soft tissue contrast is needed, but CT is usually sufficient. Following imaging, a definitive diagnosis is made by histopathological examination of the excised tissue. In some cases, a biopsy may be taken via endoscopic guidance or fine-needle aspiration, but this is not always necessary if surgical excision is planned. The diagnostic algorithm should also include a complete blood count, serum biochemistry, and urinalysis to assess overall health and anesthetic risk. If otitis media is suspected, a myringotomy and culture may be performed to guide antimicrobial therapy.

Laboratory findings in nasopharyngeal polyps are generally nonspecific. Complete blood count may show mild leukocytosis or eosinophilia if there is concurrent infection or inflammation. Serum biochemistry is usually within normal limits, but chronic inflammation may lead to mild hyperglobulinemia. Urinalysis is typically unremarkable. If otitis media is present, cytological evaluation of ear discharge may reveal inflammatory cells and bacteria. Culture and sensitivity of the discharge or middle ear effusion can guide antibiotic therapy. In cases with vestibular signs, cerebrospinal fluid analysis may be considered to rule out other causes, but it is usually normal. Inflammatory biomarkers such as serum amyloid A (SAA) may be elevated in chronic inflammatory conditions, but they are not specific for polyps. Coagulation profile is not routinely indicated unless surgery is planned and there is a history of bleeding disorders.

Radiography: Lateral and ventrodorsal skull radiographs may show a soft tissue opacity in the nasopharynx, dorsal displacement of the soft palate, or increased opacity of the tympanic bulla (suggesting otitis media). However, radiographs are not sensitive for small polyps. Computed Tomography (CT): CT is the gold standard for imaging nasopharyngeal polyps. It provides high-resolution cross-sectional images that can clearly delineate the polyp, its origin (nasopharynx, eustachian tube, or middle ear), and the extent of middle ear involvement. CT findings include a soft tissue mass in the nasopharynx, often with a stalk extending into the tympanic cavity. The tympanic bulla may be filled with soft tissue or fluid, and there may be thickening of the bulla wall. CT is also useful for surgical planning, as it helps determine whether a ventral bulla osteotomy is necessary. Magnetic Resonance Imaging (MRI): MRI may be used if there is concern for intracranial extension or if soft tissue contrast is needed, but it is not routinely required. MRI can provide excellent soft tissue detail and may help differentiate polyps from neoplasia. Ultrasonography: Not typically used for nasopharyngeal polyps, but it may be used to evaluate the tympanic bulla in some cases. Fluoroscopy: May be used during surgery to guide traction-avulsion, but it is not essential.

Cytology: Fine-needle aspiration of a nasopharyngeal polyp is rarely performed due to the risk of hemorrhage and the difficulty of accessing the site. If cytology is obtained, it typically shows a mixture of inflammatory cells (lymphocytes, plasma cells, neutrophils) and respiratory epithelial cells, with no evidence of malignancy. Histopathology: The definitive diagnosis is made by histopathological examination of the excised polyp. Grossly, the polyp is a smooth, pink to red, pedunculated mass. Microscopically, it is composed of a fibrovascular core covered by respiratory epithelium (ciliated pseudostratified columnar epithelium) or squamous epithelium if there is chronic irritation. The stroma contains variable numbers of inflammatory cells, including lymphocytes, plasma cells, and neutrophils, as well as fibroblasts and collagen. There may be areas of hemorrhage, necrosis, and edema. The polyp is benign, with no evidence of malignant transformation. Surgical margins should be evaluated to ensure complete excision, as incomplete removal is associated with a higher risk of recurrence.

The treatment of choice for nasopharyngeal polyps is surgical excision. Two main surgical techniques are described: traction-avulsion and ventral bulla osteotomy (VBO). Traction-avulsion is a minimally invasive technique that involves grasping the polyp with forceps and gently avulsing it from its attachment. This is often performed via the oral cavity or external ear canal. However, traction-avulsion has a higher recurrence rate (up to 50%) if the polyp originates from the middle ear, as the stalk may not be completely removed. Ventral bulla osteotomy is a more invasive procedure that involves creating a surgical opening in the tympanic bulla to access the middle ear and remove the entire polyp, including its origin. This technique is recommended for polyps with middle ear involvement, as it allows complete removal and reduces the risk of recurrence. The surgical approach for VBO involves a ventral midline incision over the tympanic bulla, followed by blunt dissection to expose the bulla. A burr or osteotome is used to create a bone window, and the polyp is carefully dissected from the middle ear. The bulla is then flushed and may be packed with a local antibiotic. Postoperative care includes pain management, antibiotics, and anti-inflammatory medications. In some cases, medical management with corticosteroids may be attempted, but it is not curative and is generally reserved for cases where surgery is not feasible. The choice of technique depends on the extent of the polyp, as determined by imaging. For polyps confined to the nasopharynx, traction-avulsion may be sufficient, but for those with middle ear involvement, VBO is preferred.

The prognosis for nasopharyngeal polyps is generally good to excellent with complete surgical excision. The recurrence rate is low (approximately 10-15%) when the polyp is completely removed, especially if VBO is performed for middle ear involvement. However, recurrence is more common (up to 50%) with traction-avulsion alone, particularly if the polyp originates from the middle ear. Complications such as postoperative infection, hemorrhage, and vestibular signs (if VBO is performed) are possible but usually transient. The overall success rate, defined as resolution of clinical signs, is high, with most animals showing improvement within days to weeks after surgery. Negative prognostic indicators include incomplete excision, chronic otitis media, and the presence of concurrent respiratory disease. Long-term follow-up is recommended to monitor for recurrence.

Postoperative follow-up for nasopharyngeal polyps includes: 1) Immediate postoperative care: Monitor for respiratory distress, hemorrhage, and pain. Administer analgesics (e.g., buprenorphine 0.01-0.02 mg/kg IV/IM q8-12h, or meloxicam 0.1 mg/kg PO q24h for cats) and antibiotics (e.g., amoxicillin-clavulanate 12.5-25 mg/kg PO q12h) for 7-14 days. 2) Suture removal: If skin sutures are placed (e.g., for VBO), they are typically removed in 10-14 days. 3) Recheck examination: Schedule a recheck at 2 weeks postoperatively to assess healing and resolution of clinical signs. 4) Imaging: If VBO was performed, a follow-up CT or radiograph may be recommended at 4-8 weeks to confirm complete resolution and assess for recurrence. 5) Long-term monitoring: Owners should be advised to monitor for recurrence of clinical signs (e.g., stertor, nasal discharge, head tilt) and return for re-evaluation if they occur. Annual physical examinations are recommended. 6) Activity restrictions: Restrict activity for 2 weeks postoperatively to allow healing, especially if VBO was performed. 7) Physical therapy: Not typically required, but gentle cleaning of the ear may be needed if otorrhea persists.

Clinical Pearls: 1) Always perform a thorough oral examination under sedation or anesthesia to visualize the nasopharynx; a dental mirror or endoscope can aid in visualization. 2) CT is essential for surgical planning, as it reveals the extent of middle ear involvement and helps decide between traction-avulsion and VBO. 3) When performing traction-avulsion, grasp the polyp firmly with forceps and apply steady, gentle traction to avoid breaking the stalk. 4) In VBO, use a high-speed burr to create a bone window, and be careful to avoid damage to the hypoglossal nerve and carotid artery. 5) Postoperative vestibular signs are common after VBO but usually resolve within 1-2 weeks; inform owners in advance. 6) Consider culture of middle ear effusion during VBO to guide antibiotic therapy. Pitfalls: 1) Incomplete removal of the polyp stalk, especially in traction-avulsion, leads to recurrence. 2) Failure to perform VBO when middle ear involvement is present increases recurrence risk. 3) Overzealous traction during avulsion can cause hemorrhage or damage to surrounding structures. 4) Inadequate postoperative pain management can lead to patient distress and poor recovery. 5) Not addressing concurrent otitis media can lead to persistent infection and complications.

Perioperative drug protocols for nasopharyngeal polyp surgery are based on Plumb's Veterinary Drug Handbook. Preoperative: Administer a broad-spectrum antibiotic such as cefazolin (22 mg/kg IV) 30 minutes before incision, and repeat intraoperatively if surgery lasts >90 minutes. For postoperative, continue antibiotics for 7-14 days, e.g., amoxicillin-clavulanate (12.5-25 mg/kg PO q12h) or clindamycin (11 mg/kg PO q12h) if anaerobic infection is suspected. Analgesia: Preoperative opioids such as buprenorphine (0.01-0.02 mg/kg IV/IM) or methadone (0.2-0.5 mg/kg IV/IM) can be given. Postoperatively, provide multimodal analgesia: NSAIDs (e.g., meloxicam 0.1 mg/kg PO q24h for cats, or carprofen 2.2 mg/kg PO q12h for dogs) for 3-5 days, and opioids as needed (e.g., buprenorphine 0.01-0.02 mg/kg IV/IM q8-12h for 24-48 hours). Local anesthesia: For VBO, a local block with bupivacaine (1-2 mg/kg) may be administered at the surgical site. Anti-inflammatory: Corticosteroids may be used to reduce inflammation, e.g., prednisolone (0.5-1 mg/kg PO q12h) for 3-5 days, but use with caution in cats. Antiemetics: If postoperative nausea occurs, maropitant (1 mg/kg IV/PO q24h) can be used. Gastroprotectants: If NSAIDs are used, consider famotidine (0.5-1 mg/kg PO q12h) or omeprazole (0.7-1 mg/kg PO q24h).

The literature on nasopharyngeal polyps is primarily composed of retrospective case series and expert opinion. A landmark study by Kapatkin et al. (1990) reported a recurrence rate of 50% with traction-avulsion alone, compared to 10% with ventral bulla osteotomy, establishing VBO as the preferred technique for middle ear polyps. Another study by Anderson et al. (2000) evaluated the use of CT in diagnosing nasopharyngeal polyps and found it to be highly sensitive for detecting middle ear involvement. A more recent study by Greci et al. (2014) compared traction-avulsion and VBO and found that VBO had a lower recurrence rate but a higher complication rate, including postoperative vestibular syndrome. The ACVS consensus guidelines recommend CT imaging for all suspected cases and VBO for polyps with middle ear involvement. The use of corticosteroids as an adjunct to surgery has been suggested, but evidence is limited. Overall, the evidence supports surgical excision as the definitive treatment, with VBO being the most effective for preventing recurrence.